Evidence for the presence in unimmunized mice of two populations of bone marrow derived B lymphocytes, defined by differences in adherence properties.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 4141931)

Published in Cell Immunol on March 15, 1974

Authors

J W Schrader

Articles by these authors

(truncated to the top 100)

Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol (1983) 4.51

Inducible expression of H-2 and Ia antigens on brain cells. Nature (1984) 3.48

Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. Proc Natl Acad Sci U S A (1975) 2.39

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30

Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells. J Exp Med (1976) 2.05

Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J (1994) 1.97

The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci U S A (1981) 1.97

Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens. J Exp Med (1972) 1.89

Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science (1986) 1.84

The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J Immunol (1981) 1.83

Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol (1991) 1.82

Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens. J Exp Med (1974) 1.75

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol (1984) 1.73

Mechanism of activation of the bone marrow-derived lymphocyte. 3. A distinction between a macrophage-produced triggering signal and the amplifying effect on triggered B lymphocytes of allogeneic interactions. J Exp Med (1973) 1.59

The panspecific hemopoietin of activated T lymphocytes (interleukin-3). Annu Rev Immunol (1986) 1.57

In in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and Ia-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells. J Immunol (1981) 1.55

Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor. Proc Natl Acad Sci U S A (1982) 1.53

Frequency of mast cell precursors in normal tissues determined by an in vitro assay: antigen induces parallel increases in the frequency of P cell precursors and mast cells. J Immunol (1983) 1.52

The role of T cells in IgG production; thymus-dependent antigens induce B cell memory in the absence of T cells. J Immunol (1975) 1.51

P cell-stimulating factor: biochemical characterization of a new T cell-derived factor. J Immunol (1981) 1.50

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50

p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci U S A (1992) 1.46

Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice. Mol Cell Biol (1987) 1.46

Specific activation of the bone marrow-derived lymphocyte by antigen presented in a non-multivalent form. J Exp Med (1973) 1.46

Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol (1985) 1.45

A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proc Natl Acad Sci U S A (1996) 1.45

Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J Biol Chem (2000) 1.42

Intramucosal lymphocytes of the gut: Lyt-2 and thy-1 phenotype of the granulated cells and evidence for the presence of both T cells and mast cell precursors. J Immunol (1983) 1.31

Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J Biol Chem (1994) 1.31

An examination of differences in serum antibody specificities and hypersensitivity reactions as contributing factors to chronic infection with the intestinal protozoan parasite, Giardia muris, in mice. Aust J Exp Biol Med Sci (1983) 1.30

Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase. J Biol Chem (1994) 1.28

Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells. J Biol Chem (1984) 1.27

Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci U S A (1982) 1.22

A con A-stimulated T-cell hybridoma releases factors affecting haematopoietic colony-forming cells and B-cell antibody responses. Nature (1980) 1.21

In vitro studies on lymphocyte differentiation. I. Long term in vitro culture of cells giving rise to functional lymphocytes in irradiated mice. J Exp Med (1978) 1.19

Expression of Thy-1 antigen is not limited to T cells in cultures of mouse hemopoietic cells. Proc Natl Acad Sci U S A (1982) 1.15

Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J Biol Chem (1992) 1.15

Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor. J Immunol (1982) 1.15

Multiple hemopoietic growth factors stimulate activation of mitogen-activated protein kinase family members. J Immunol (1992) 1.14

Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature (1982) 1.14

Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli. J Biol Chem (1998) 1.13

Induction of immunological tolerance to a thymus-dependent antigen in the absence of thymus-derived cells. J Exp Med (1974) 1.12

Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J Lipid Res (2001) 1.11

Delayed hypersensitivity in mast-cell-deficient mice. J Immunol (1983) 1.10

Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J Biol Chem (1994) 1.09

M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood (1999) 1.09

Nature of the T-cell receptor. Both the T-cell receptor and antigen-specific T-cell-derived factors are coded for by V genes but express anti-self idiotypes indirectly determined by major histocompatibility complex genes. Scand J Immunol (1979) 1.07

Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity. J Immunol (1988) 1.07

Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem (1997) 1.07

Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. J Biol Chem (1994) 1.06

Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes (1985) 1.06

Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells. Proc Natl Acad Sci U S A (1983) 1.04

IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol (1999) 1.03

Bone marrow differentiation in vitro. Crit Rev Immunol (1983) 1.03

Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem (1997) 1.02

Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma. J Immunol (1984) 1.01

The regulation of growth and differentiation of a murine B cell lymphoma. I. Lipopolysaccharide-induced differentiation. J Immunol (1981) 1.01

Mechanism of effector-cell blockade. I. Antigen-induced suppression of Ig synthesis in a hybridoma cell line, and correlation with cell-associated antigen. J Exp Med (1980) 1.01

Antiviral antibodies inhibit the lysis of tumour cells by anti-H--2 sera. Nature (1976) 1.00

P-cell stimulating factor: characterization, action on multiple lineages of bone-marrow-derived cells and role in oncogenesis. Immunol Rev (1983) 1.00

Structural homologies among the hemopoietins. Proc Natl Acad Sci U S A (1986) 1.00

p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine (2000) 0.99

Strategies for the analysis of accessory-cell function: the in vitro cloning and characterization of the P cell. Immunol Rev (1980) 0.97

A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor. J Immunol (1982) 0.96

Intracisternal A-type particle-mediated activations of cytokine genes in a murine myelomonocytic leukemia: generation of functional cytokine mRNAs by retroviral splicing events. Mol Cell Biol (1991) 0.96

Murine c-myc retroviruses alter the growth requirements of myeloid cell lines. Oncogene Res (1987) 0.95

The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-gamma. Eur J Immunol (2001) 0.95

Proprioceptive neuromuscular facilitation techniques in sports medicine: a reassessment. J Athl Train (1997) 0.95

Antibodies to transcobalamin II block in vitro proliferation of leukemic cells. Blood (1997) 0.94

Regulation of the immune response by IgM antibody: a paradoxical suppression of the in vitro primary immune response to sheep erythrocytes by passive IgM. Aust J Exp Biol Med Sci (1973) 0.94

The mechanism of bone marrow-derived (B) lymphocyte activation. I. Early events in antigen-induced triggering in the presence of polymerized flagellin. Eur J Immunol (1974) 0.94

Antagonism of B lymphocyte mitogenesis by anti-immunoglobulin antibody. J Immunol (1975) 0.94

The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol (1997) 0.94

In vivo transfer of persisting (P) cells; further evidence for their identity with T-dependent mast cells. J Immunol (1984) 0.93

A new, simple method for the preparation of lymphocytes bearing specific receptors. Eur J Immunol (1974) 0.93

Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways. J Immunol (1992) 0.93

In vitro studies on lymphocyte differentiation. II. Generation of terminal deoxynucleotidyl transferase-positive cells in long-term cultures of mouse bone marrow. J Immunol (1979) 0.93

T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A. J Immunol (1981) 0.93

Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem (1995) 0.92

SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates. J Biol Chem (1997) 0.92

Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. II. Evidence for glycosylation of T cell growth factor, T cell replacing factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1982) 0.89

Stimulation of bone marrow-derived and peritoneal macrophages by a T lymphocyte-derived hemopoietic growth factor, persisting cell-stimulating factor. Blood (1985) 0.89

Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol Reprod (1993) 0.87

Modulation of c-kit mRNA and protein by hemopoietic growth factors. Mol Cell Biol (1991) 0.87

A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth. Oncogene (2001) 0.87

Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood (1997) 0.86

Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. J Immunol (1991) 0.86

P cell stimulating factor release: a useful assay of T cell activation in vitro. Int Arch Allergy Appl Immunol (1986) 0.86

An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J Biol Chem (1997) 0.85

The in vitro induction of immunological tolerance in the B lymphocyte by oligovalent thymus-dependent antigens. J Exp Med (1975) 0.85

The mechanism of antigenic competition. I. The macrophage as a site of a reversible block of T-B lymphocyte collaboration. Eur J Immunol (1973) 0.85

Mechanism of antigenic competition. II. Induction by specific T cell products. Cell Immunol (1974) 0.85

The mechanism of bone marrow-derived (B) lymphocyte activation. II. A "second signal" for antigen-specific activation provided by flagellin and lipopolysaccharide. Eur J Immunol (1974) 0.85

Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines. Immunology (1987) 0.84

Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3. J Immunol (1987) 0.84

Role of a single haemopoietic growth factor in multiple proliferative disorders of haemopoietic and related cells. Lancet (1984) 0.84

Characterization of hemopoietic growth factors from T cells and the myelomonocytic leukemia WEHI-3B. Exp Hematol (1985) 0.84

Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival. Blood (1999) 0.84

B lymphocyte-antigen interactions in the initiation of tolerance or immunity. Transplant Rev (1975) 0.84

Expression of interleukin-1 beta gene in candidate human hematopoietic stem cells. Blood (1994) 0.83